What does MEDISPHERE do?

MEDISPHERE is a wholesaler in Hamois. Private Limited, started on 19 March 2010, 1 establishment.

What is the address of MEDISPHERE?

The registered office of MEDISPHERE is located at Rue de la Croix Limont,Emptinne 8, 5363 Hamois.

Is MEDISPHERE still active?

Yes. According to the CBE (30 October 2026) MEDISPHERE is active, legal situation “Normale toestand”, started on 19 March 2010.

Is MEDISPHERE registered on Peppol?

Yes, MEDISPHERE is registered on the Peppol network with ID 0208:0824094578.

What is the enterprise number of MEDISPHERE?

The enterprise number of MEDISPHERE is BE0824094578.

When was MEDISPHERE founded?

MEDISPHERE was founded on 19 March 2010.

Who are the directors of MEDISPHERE?

According to the 2025 annual accounts, the directors of MEDISPHERE are: FOXLEX SRL, PHARMACIE MOLITOR-MEIRLAEN SRL.

Is MEDISPHERE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 March 2010; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MEDISPHERE make in 2025?

MEDISPHERE posted a profit after taxes of € 907,218 in financial year 2025.

What is the revenue of MEDISPHERE?

As a small company, MEDISPHERE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,633,164.

How much does an employee at MEDISPHERE earn?

The average wage cost per full-time employee at MEDISPHERE was € 55,700 in 2025: staff costs of € 267,524 for 4.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does MEDISPHERE have?

According to the 2025 annual accounts, MEDISPHERE has 4.8 full-time equivalents (FTE).

MEDISPHERE (Private Limited) - Hamois - BE0824094578

Dossier MEDISPHERE, printed on 30 October 2026 from databakkes.be/en/0824094578/medisphere. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDISPHERE from Hamois, company number BE0824094578, closed financial year 2025 with a result of € 907,218 after tax. For that financial year MEDISPHERE recorded a gross margin of € 1.6 million and equity of € 3.6 million. Compared with financial year 2024, the result moved from € 587,535 to € 907,218. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 3.6 million

▲ 19% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 907,218

▲ 54% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.2 million

▲ 26% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 330,000 paid out

36 % of the profit went to the shareholders, mostly to PHARMACIE MOLITOR-MEIRLAEN (50 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

4.8

▲ 1.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 267,524

▲ 35% vs 2024

€ 55,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 125,094

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.2 million

▼ 11% vs 2024

€ 144,009 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 609,434

▼ 21% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 213,875

▲ 52% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 912,756 Gross margin 2022: € 912,756 First fiscal year in the series	€ 1,082,177 Gross margin 2023: € 1,082,177 ▲ 19% vs 2022 (€ 912,756) Favourable step	€ 1,173,771 Gross margin 2024: € 1,173,771 ▲ 8% vs 2023 (€ 1,082,177) Favourable step	€ 1,633,164 Gross margin 2025: € 1,633,164 ▲ 39% vs 2024 (€ 1,173,771) Favourable step	▲ 39%
Profit after taxes	€ 552,346 Profit after taxes 2022: € 552,346 First fiscal year in the series	€ 531,460 Profit after taxes 2023: € 531,460 ▼ 4% vs 2022 (€ 552,346) Unfavourable step	€ 587,535 Profit after taxes 2024: € 587,535 ▲ 11% vs 2023 (€ 531,460) Favourable step	€ 907,218 Profit after taxes 2025: € 907,218 ▲ 54% vs 2024 (€ 587,535) Favourable step	▲ 54%
Equity	€ 2,079,130 Equity 2022: € 2,079,130 First fiscal year in the series	€ 2,517,787 Equity 2023: € 2,517,787 ▲ 21% vs 2022 (€ 2,079,130) Favourable step	€ 3,012,518 Equity 2024: € 3,012,518 ▲ 20% vs 2023 (€ 2,517,787) Favourable step	€ 3,586,932 Equity 2025: € 3,586,932 ▲ 19% vs 2024 (€ 3,012,518) Favourable step	▲ 19%
Total debts	€ 3,094,319 Total debts 2022: € 3,094,319 First fiscal year in the series	€ 2,744,847 Total debts 2023: € 2,744,847 ▼ 11% vs 2022 (€ 3,094,319) Favourable step	€ 2,445,758 Total debts 2024: € 2,445,758 ▼ 11% vs 2023 (€ 2,744,847) Favourable step	€ 2,449,333 Total debts 2025: € 2,449,333 Unchanged (€ 2,445,758) Unfavourable step
Cash	€ 1,324,738 Cash 2022: € 1,324,738 First fiscal year in the series	€ 507,174 Cash 2023: € 507,174 ▼ 62% vs 2022 (€ 1,324,738) Unfavourable step	€ 936,655 Cash 2024: € 936,655 ▲ 85% vs 2023 (€ 507,174) Favourable step	€ 1,182,314 Cash 2025: € 1,182,314 ▲ 26% vs 2024 (€ 936,655) Favourable step	▲ 26%
Land & buildings	€ 1,604,833 Land & buildings 2022: € 1,604,833 First fiscal year in the series	€ 1,590,724 Land & buildings 2023: € 1,590,724 ▼ 1% vs 2022 (€ 1,604,833) Unchanged	€ 1,626,447 Land & buildings 2024: € 1,626,447 ▲ 2% vs 2023 (€ 1,590,724) Unchanged	€ 1,567,741 Land & buildings 2025: € 1,567,741 ▼ 4% vs 2024 (€ 1,626,447) Unchanged	▼ 4%
Retained profit	€ 2,029,354 Retained profit 2022: € 2,029,354 First fiscal year in the series	€ 2,470,814 Retained profit 2023: € 2,470,814 ▲ 22% vs 2022 (€ 2,029,354) Favourable step	€ 2,968,349 Retained profit 2024: € 2,968,349 ▲ 20% vs 2023 (€ 2,470,814) Favourable step	€ 3,545,567 Retained profit 2025: € 3,545,567 ▲ 19% vs 2024 (€ 2,968,349) Favourable step	▲ 19%
Dividend	€ 90,000 Dividend 2022: € 90,000 First fiscal year in the series	€ 90,000 Dividend 2023: € 90,000 Unchanged (€ 90,000) Unchanged	€ 90,000 Dividend 2024: € 90,000 Unchanged (€ 90,000) Unchanged	€ 330,000 Dividend 2025: € 330,000 ▲ 267% vs 2024 (€ 90,000) Unchanged	▲ 267%
Bank debt	€ 1,634,907 Bank debt 2022: € 1,634,907 First fiscal year in the series	€ 1,485,942 Bank debt 2023: € 1,485,942 ▼ 9% vs 2022 (€ 1,634,907) Favourable step	€ 1,345,120 Bank debt 2024: € 1,345,120 ▼ 9% vs 2023 (€ 1,485,942) Favourable step	€ 1,203,040 Bank debt 2025: € 1,203,040 ▼ 11% vs 2024 (€ 1,345,120) Favourable step	▼ 11%
Balance sheet total	€ 5,173,449 Balance sheet total 2022: € 5,173,449 First fiscal year in the series	€ 5,262,633 Balance sheet total 2023: € 5,262,633 ▲ 2% vs 2022 (€ 5,173,449) Unchanged	€ 5,458,276 Balance sheet total 2024: € 5,458,276 ▲ 4% vs 2023 (€ 5,262,633) Unchanged	€ 6,036,265 Balance sheet total 2025: € 6,036,265 ▲ 11% vs 2024 (€ 5,458,276) Unchanged	▲ 11%
Employees (FTE)	3.5 Employees (FTE) 2022: 3.5 First fiscal year in the series	3.8 Employees (FTE) 2023: 3.8 ▲ 0.3 vs 2022 (3.5) Unchanged	3.2 Employees (FTE) 2024: 3.2 ▼ 0.6 vs 2023 (3.8) Unchanged	4.8 Employees (FTE) 2025: 4.8 ▲ 1.6 vs 2024 (3.2) Unchanged	▲ 1.6

Key figures of MEDISPHERE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDISPHERE?

What happened at MEDISPHERE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 907,218 (▲ 54% vs 2024). filed late Source: NBB ↗
Apr 1, 2010 New establishment in Hamois. KBO
Mar 19, 2010 Start of the company according to the CBE. KBO

In short

From € 552,346 profit in 2022 to € 907,218 profit in 2025.

Paid € 663,265 in corporate taxes since 2022.

Best year ever: 2025, with € 907,218 profit.

On average € 340,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

PHARMACIE MOLITOR-MEIRLAEN 50%

The stake of PHARMACIE MOLITOR-MEIRLAEN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

MEDISPHERE

Behind MEDISPHERE are FOXLEX SRL and PHARMACIE MOLITOR-MEIRLAEN SRL. The shares are held by PHARMACIE MOLITOR-MEIRLAEN (50%).

Directors

According to the 2025 annual accounts

FOXLEX SRL

Director · represented by Sébastien MOLITOR

PHARMACIE MOLITOR-MEIRLAEN SRL

Director · represented by Michaël MOLITOR

Shareholders

PHARMACIE MOLITOR-MEIRLAEN

50%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Croix Limont,Emptinne 8

5363 Hamois

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

SANACURE

€ 435,147 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0824.094.578

VAT number

BE 0824.094.578

Registered office

Rue de la Croix Limont,Emptinne 8, 5363 Hamois

Names & denominations

MEDISPHERE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

19 March 2010

Peppol

Active · Active since 13 Jan 2026

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Activiteiten van adviesbureaus op het gebied van public relations en communicatie

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

Adviesbureaus op het gebied van public relations en communicatie

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDISPHERE

Financials

What happened to MEDISPHERE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions